BD Diagnostics, a segment of Becton, Dickinson and Co., has announced it has received FDA clearance for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD Veritor system for ...

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B, ...

Becton, Dickinson and Company BDX, popularly known as BD, received emergency use authorization (“EUA”) from the FDA for a new, rapid antigen test, which can simultaneously identify SARS-CoV-2, ...

December 19, 2011 — A new rapid test for diagnosing influenza types A and B — the first to offer a digital readout of results — has been granted a Clinical Laboratory Improvement Amendments (CLIA) ...